Literature DB >> 28131088

Long-term passage of Vif-null HIV-1 in CD4+ T cells expressing sub-lethal levels of APOBEC proteins fails to develop APOBEC resistance.

Eri Miyagi1, Sandra Kao1, Miyoshi Fumitaka1, Alicia Buckler-White1, Ron Plishka1, Klaus Strebel2.   

Abstract

APOBEC3G (A3G) is a cytidine deaminase with potent antiviral activity that is antagonized by Vif. A3G is expressed in a cell type-specific manner and some semi-permissive cells, including A3.01, express A3G but fail to block replication of Vif-null HIV-1. Here we explored the semi-permissive nature of A3.01 cells and found it to be defined exclusively by the levels of A3G. Indeed, minor changes in A3G levels rendered A3.01 cells either fully permissive or non-permissive for Vif-null HIV-1. Our data indicate that A3.01 cells express sub-lethal levels of catalytically active A3G that affects Vif-null HIV-1 at the proviral level but does not completely block virus replication due to purifying selection. Attempts to use the selective pressure exerted by such sub-lethal levels of A3G to select for APOBEC-resistant Vif-null virus capable of replicating in H9 cells failed despite passaging virus for five months, demonstrating that Vif is a critical viral accessory protein. Published by Elsevier Inc.

Entities:  

Keywords:  A3.01 cells; APOBEC3G; Antiviral resistance; Cytidine deaminase; Deamination; HIV-1; Hypermutation; Purifying selection; Vif; Viral evolution

Mesh:

Substances:

Year:  2017        PMID: 28131088      PMCID: PMC5337162          DOI: 10.1016/j.virol.2017.01.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  69 in total

1.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

2.  Moderate influence of human APOBEC3F on HIV-1 replication in primary lymphocytes.

Authors:  Lubbertus C F Mulder; Marcel Ooms; Susan Majdak; Jordan Smedresman; Caitlin Linscheid; Ariana Harari; Andrea Kunz; Viviana Simon
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.

Authors:  Tomoko Kobayashi; Yoshiki Koizumi; Junko S Takeuchi; Naoko Misawa; Yuichi Kimura; Satoru Morita; Kazuyuki Aihara; Yoshio Koyanagi; Shingo Iwami; Kei Sato
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.

Authors:  A M Borman; C Quillent; P Charneau; C Dauguet; F Clavel
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

5.  Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.

Authors:  Keyang Chen; Jialing Huang; Chune Zhang; Sophia Huang; Giuseppe Nunnari; Feng-xiang Wang; Xiangrong Tong; Ling Gao; Kristi Nikisher; Hui Zhang
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

6.  A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.

Authors:  Anjie Zhen; Tao Wang; Ke Zhao; Yong Xiong; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

7.  Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1.

Authors:  Eri Miyagi; Sandrine Opi; Hiroaki Takeuchi; Mohammad Khan; Ritu Goila-Gaur; Sandra Kao; Klaus Strebel
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

8.  Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates.

Authors:  Véronique Zennou; Paul D Bieniasz
Journal:  Virology       Date:  2006-02-07       Impact factor: 3.616

9.  Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.

Authors:  Gang Peng; Ke Jian Lei; Wenwen Jin; Teresa Greenwell-Wild; Sharon M Wahl
Journal:  J Exp Med       Date:  2006-01-17       Impact factor: 14.307

10.  CEM-T4 cells do not lack an APOBEC3G cofactor.

Authors:  Guylaine Haché; Reuben S Harris
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

View more
  3 in total

1.  Inhibition of Vif-Mediated Degradation of APOBEC3G through Competitive Binding of Core-Binding Factor Beta.

Authors:  Eri Miyagi; Sarah Welbourn; Sayaka Sukegawa; Helena Fabryova; Sandra Kao; Klaus Strebel
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

Review 2.  Vpr and Its Cellular Interaction Partners: R We There Yet?

Authors:  Helena Fabryova; Klaus Strebel
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

3.  The Expression Level of HIV-1 Vif Is Optimized by Nucleotide Changes in the Genomic SA1D2prox Region during the Viral Adaptation Process.

Authors:  Takaaki Koma; Naoya Doi; Mai Takemoto; Kyosuke Watanabe; Hideki Yamamoto; Satoshi Nakashima; Akio Adachi; Masako Nomaguchi
Journal:  Viruses       Date:  2021-10-15       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.